Superkiller for superbugs

Tri-Air Developments has developed a device that could win the war against MRSA and bird flu while revolutionising the way hospitals are cleaned.

The device ‘scrubs’ the air by combining the use of three existing decontamination techniques: non-thermal plasma, ultraviolet catalysis, and Open Air Factor (OAF). According to Tri-Air this combination allows the unit to overcome each of the techniques shortcomings, making it 100 times more effective than current methods of decontamination.

‘The applications for this technology are enormous,’ said Gideon Davenport, CEO of Tri-Air. ‘Especially in America and South East Asia where air quality is more of an issue. The actual application is literally where anybody exists indoors: residential homes; corporate offices; hospitals; and transportation. There is also the potential for use during pandemics. Its actual value is almost impossible to estimate.

‘As it uses existing technology it could be assembled from off the shelf components so it wont necessarily have to be priced expensively. We had an estimate that in a mass consumer market it would cost around $50-70 to make.’